MX2021009485A - Metodo para el tratamiento de la osteoartritis con una combinacion de exosomas de celulas madre mesenquimales, celulas madre mesenquimales sinoviales, y soportes. - Google Patents

Metodo para el tratamiento de la osteoartritis con una combinacion de exosomas de celulas madre mesenquimales, celulas madre mesenquimales sinoviales, y soportes.

Info

Publication number
MX2021009485A
MX2021009485A MX2021009485A MX2021009485A MX2021009485A MX 2021009485 A MX2021009485 A MX 2021009485A MX 2021009485 A MX2021009485 A MX 2021009485A MX 2021009485 A MX2021009485 A MX 2021009485A MX 2021009485 A MX2021009485 A MX 2021009485A
Authority
MX
Mexico
Prior art keywords
synovial
scaffolds
treating osteoarthritis
combination
stem cells
Prior art date
Application number
MX2021009485A
Other languages
English (en)
Inventor
Timothy Alexander Moseley
Kenneth Allen Pettine
Original Assignee
Direct Biologics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Direct Biologics Llc filed Critical Direct Biologics Llc
Publication of MX2021009485A publication Critical patent/MX2021009485A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5184—Virus capsids or envelopes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

En la presente se divulgan métodos para el tratamiento de la osteoartritis que pueden ser un procedimiento artroscópico de una sola etapa y que pueden incluir extraer células madre mesenquimales (MSC) sinoviales del sinovio mediante un dispositivo de cepillo; cubrir el cartílago articular en una articulación afectada con un soporte; y colocar exosomas de MSC concentrados en la articulación afectada para estimular la diferenciación de las MSC sinoviales en células del cartílago articular.
MX2021009485A 2019-02-07 2020-02-07 Metodo para el tratamiento de la osteoartritis con una combinacion de exosomas de celulas madre mesenquimales, celulas madre mesenquimales sinoviales, y soportes. MX2021009485A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962802310P 2019-02-07 2019-02-07
US201962908853P 2019-10-01 2019-10-01
PCT/US2020/017341 WO2020163803A1 (en) 2019-02-07 2020-02-07 Method for treating osteoarthritis with a combination of mesenchymal stem cell exosomes, synovial mesencymal stem cells, and scaffolds

Publications (1)

Publication Number Publication Date
MX2021009485A true MX2021009485A (es) 2021-09-23

Family

ID=71947899

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021009485A MX2021009485A (es) 2019-02-07 2020-02-07 Metodo para el tratamiento de la osteoartritis con una combinacion de exosomas de celulas madre mesenquimales, celulas madre mesenquimales sinoviales, y soportes.

Country Status (11)

Country Link
US (1) US20220125848A1 (es)
EP (1) EP3920946A4 (es)
JP (1) JP2022519700A (es)
KR (1) KR20210137026A (es)
AU (1) AU2020217808A1 (es)
BR (1) BR112021015549A2 (es)
CA (1) CA3129678A1 (es)
IL (1) IL285419A (es)
MX (1) MX2021009485A (es)
SG (1) SG11202108470YA (es)
WO (1) WO2020163803A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114891736A (zh) * 2022-07-01 2022-08-12 中晶生物技术股份有限公司 一种三维培养的间充质干细胞外泌体增强软骨细胞生长与特性维持的方法及其应用
CN115212356A (zh) * 2022-07-08 2022-10-21 上海揽微赛尔生物科技有限公司 促进中胚层源性细胞组织再生的复合物、制备方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9427450B2 (en) * 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
US9828603B2 (en) * 2012-08-13 2017-11-28 Cedars Sinai Medical Center Exosomes and micro-ribonucleic acids for tissue regeneration

Also Published As

Publication number Publication date
WO2020163803A1 (en) 2020-08-13
IL285419A (en) 2021-09-30
AU2020217808A8 (en) 2021-09-16
US20220125848A1 (en) 2022-04-28
BR112021015549A2 (pt) 2021-10-26
EP3920946A4 (en) 2022-11-09
EP3920946A1 (en) 2021-12-15
KR20210137026A (ko) 2021-11-17
AU2020217808A1 (en) 2021-09-02
CA3129678A1 (en) 2020-08-13
JP2022519700A (ja) 2022-03-24
SG11202108470YA (en) 2021-09-29

Similar Documents

Publication Publication Date Title
MX2021009485A (es) Metodo para el tratamiento de la osteoartritis con una combinacion de exosomas de celulas madre mesenquimales, celulas madre mesenquimales sinoviales, y soportes.
IN2012DN02668A (es)
MX2016001247A (es) Matrices derivadas de tejido suave acelular y metodos para preparar las mismas.
AU2016216525A1 (en) Method and system for aligning a prosthesis during surgery
BRPI0921726B8 (pt) método para preparar uma composição de implante para promover o crescimento ósseo em um mamífero
WO2008054825A3 (en) Mixed cell populations for tissue repair and separation technique for cell processing
WO2009158480A3 (en) Stimulation of cartilage formation using reduced pressure treatment and chondrocytes
BR112015004650A2 (pt) implantes ósseos de compósito
MX2017005373A (es) Soporte de biomaterial para la regeneracion de mucosa oral.
GB2463209A (en) In-situ ion source cleaning for partial pressure analyzer used in process monitoring
WO2010033088A3 (en) Method of improving differentiation of chondrogenic progenitor cells
EP4177341A4 (en) METHOD FOR PRODUCING MESENCHYMAL STEM CELLS DERIVED FROM SYNOVIAL MEMBRANE AND METHOD FOR PRODUCING A CELL PRERARATION FOR JOINT TREATMENT AGENT
EA201491526A8 (ru) Способ культивирования бычьих и свиных сперматогониальных стволовых клеток без использования клеток-фидеров
WO2007127436A3 (en) Methods and compositions for repairing cartilage
EP2563385A4 (en) METHODS OF USING SOLUBLE CD24 FOR THE THERAPY OF RHEUMATOID ARTHRITIS
BR112012029472A2 (pt) processo e aparelho para o tratamento eletroquimico de compostos nitroaromáticos, e uso de um aparelho.
EA201290561A1 (ru) Технология рециркуляции
WO2014027176A3 (en) Stem cell culture method
EP3562665A4 (en) SYSTEM AND PROCESS FOR THE RECOVERY OF CARBON FIBERS USING SOLAR ENERGY
MX2014006371A (es) Andamiaje de glucomanano para cultivo e ingenieria de tejido tridimensional.
MX348503B (es) Aparato y método para generar una señal de ancho de banda ampliado a partir de una señal de audio de ancho de banda limitado.
MX2020000433A (es) Metodo para recuperar acido fosforico del lecho de residuos de fermentacion o residuos de fermentacion y reutilizacion del mismo.
RU2019142478A (ru) Способ и устройство для терапии биологической ткани электрическим током
MX2011010135A (es) Procesamiento de corriente de gas.
KR20180084235A (ko) 폐 리튬 전지 처리장치